Rising Pharmaceuticals, Inc.

risingpharma.com

Rising Pharmaceuticals is an industry leader in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ACETO COMPLETES ACQUISITION OF GENERIC PRODUCTS AND RELATED ASSETS OF CITRON PHARMA AND LUCID PHARMA

Rising Pharmaceuticals, Inc. | February 03, 2017

news image

ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has, through its wholly-owned subsidiary Rising Pharmaceuticals, completed the acquisition of generic products and related assets of Citron Pharma LLC, a pharmaceutical company focused on developing and marketing generic pharmaceutical products, and its affiliate Lucid Pharma ...

Read More

ACETO SUBSIDIARY, RISING PHARMACEUTICALS, TO LAUNCH ERYTHROMYCIN AND BENZOYL PEROXIDE TOPICAL GEL USP, 3%/5%

Rising Pharmaceuticals, Inc. | February 03, 2017

news image

ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% an FDA-approved generic version of Valeant International’s Benzamycin® Gel, 3%/5%....

Read More

ACETO SUBSIDIARY, RISING PHARMACEUTICALS, TO LAUNCH OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP

Rising Pharmaceuticals, Inc. | February 03, 2017

news image

ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Oxybutynin Chloride Extended-Release Tablets, USP, an FDA-approved generic version of Janssen Pharmaceuticals, Inc.’s Ditropan XL Tablets....

Read More

RISING PHARMA HOLDINGS, INC. COMPLETES PURCHASE OF RISING PHARMACEUTICALS, INC.

fltimes | April 22, 2019

news image

Rising Pharma Holdings, Inc., f. k. a. Shore Suven Pharma, Inc., announced today that it completed the purchase of the assets of Rising Pharmaceuticals and Rising’s subsidiaries on a cash-free and debt-free basis. Shore Suven Pharma, Inc., created as an acquisition entity to acquire the assets and affiliates of Rising Pharmaceuticals, Inc. will hereafter be called, Rising Pharma Holdings, Inc. Rising Pharmaceuticals will continue to operate seamlessly and transact all business under the Ri...

Read More
news image

ACETO COMPLETES ACQUISITION OF GENERIC PRODUCTS AND RELATED ASSETS OF CITRON PHARMA AND LUCID PHARMA

Rising Pharmaceuticals, Inc. | February 03, 2017

ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has, through its wholly-owned subsidiary Rising Pharmaceuticals, completed the acquisition of generic products and related assets of Citron Pharma LLC, a pharmaceutical company focused on developing and marketing generic pharmaceutical products, and its affiliate Lucid Pharma ...

Read More
news image

ACETO SUBSIDIARY, RISING PHARMACEUTICALS, TO LAUNCH ERYTHROMYCIN AND BENZOYL PEROXIDE TOPICAL GEL USP, 3%/5%

Rising Pharmaceuticals, Inc. | February 03, 2017

ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% an FDA-approved generic version of Valeant International’s Benzamycin® Gel, 3%/5%....

Read More
news image

ACETO SUBSIDIARY, RISING PHARMACEUTICALS, TO LAUNCH OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP

Rising Pharmaceuticals, Inc. | February 03, 2017

ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Oxybutynin Chloride Extended-Release Tablets, USP, an FDA-approved generic version of Janssen Pharmaceuticals, Inc.’s Ditropan XL Tablets....

Read More
news image

RISING PHARMA HOLDINGS, INC. COMPLETES PURCHASE OF RISING PHARMACEUTICALS, INC.

fltimes | April 22, 2019

Rising Pharma Holdings, Inc., f. k. a. Shore Suven Pharma, Inc., announced today that it completed the purchase of the assets of Rising Pharmaceuticals and Rising’s subsidiaries on a cash-free and debt-free basis. Shore Suven Pharma, Inc., created as an acquisition entity to acquire the assets and affiliates of Rising Pharmaceuticals, Inc. will hereafter be called, Rising Pharma Holdings, Inc. Rising Pharmaceuticals will continue to operate seamlessly and transact all business under the Ri...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us